1Ostapowicz G,Fontana RJ,Schiodt FV,et al.Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States[J].Ann Intern Med,2002,137(12):947
3Guengerich FP.Common and uncommon cytochrome P450 reactions related to metabolism and chemocal toxicity[J].Chem Res Toxicol,2001,14(6):611
4Park K,Williams DP,Naisbitt DJ,et al.Investigation of toxic metabolites during drug development[J].Toxicology and Applied Pharmacology,2005,207 (2 Suppl):S425
5Zollner G,Trauner M.Molecular pathogenesis of cholestasis[J].Wien Med Wochenschr,2006,156(13-14):380
6Faubion WA,Gores GJ.Death receptors in liver biology and pathobiology[J].Hepatology,1999,29(1);1
7Robin MA,LeRoy M,Descatoire V,et al.Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis[J].J Hepatol,1997,26(suppl 1):23
8Andrade RJ,Lucena MI,Alonso A,et al.HLA class Ⅱ genotype influences the type of liver injury in drug2induced idiosyncratic liver disease[J].Hepatology,2004,39(6):1603
9Schnyder B,Burkhart C,Schnyder FK,et al.Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4 + T cells from allergic individuals[J].J Immunol,2000,164(12):6647
10Ju C,Reilly TP,Bourdi M,et al.Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice[J].Chem Res Toxicol,2002,15 (12):1504
